Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in Healthy Subjects
Clinical trial NCT00470925 · TERMINATED
Trial details
- NCT number
- NCT00470925
- Sponsor
- Institute for Neurodegenerative Disorders
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2008-02-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.